Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Percutaneous Coronary Intervention | 7 | 2020 | 3646 | 0.71 | Why? |
| Coronary Thrombosis | 2 | 2020 | 433 | 0.70 | Why? |
| Coronary Angiography | 6 | 2020 | 2275 | 0.69 | Why? |
| Myocardial Infarction | 4 | 2020 | 3361 | 0.61 | Why? |
| Adiposity | 1 | 2017 | 329 | 0.56 | Why? |
| Coronary Artery Disease | 3 | 2017 | 2570 | 0.54 | Why? |
| Aortic Valve Stenosis | 2 | 2019 | 741 | 0.51 | Why? |
| Shock, Cardiogenic | 1 | 2020 | 700 | 0.51 | Why? |
| Transcatheter Aortic Valve Replacement | 2 | 2019 | 839 | 0.49 | Why? |
| Heart Valve Prosthesis | 1 | 2018 | 533 | 0.48 | Why? |
| ST Elevation Myocardial Infarction | 4 | 2020 | 3051 | 0.43 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.41 | Why? |
| Platelet Aggregation Inhibitors | 2 | 2018 | 1671 | 0.40 | Why? |
| Colchicine | 3 | 2021 | 730 | 0.37 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.34 | Why? |
| Radial Artery | 2 | 2018 | 132 | 0.33 | Why? |
| Acute Coronary Syndrome | 2 | 2018 | 2107 | 0.33 | Why? |
| Gout | 2 | 2018 | 85 | 0.32 | Why? |
| Diet | 1 | 2017 | 2052 | 0.29 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.27 | Why? |
| Myocardial Ischemia | 4 | 2020 | 781 | 0.25 | Why? |
| Aortic Valve | 2 | 2019 | 664 | 0.23 | Why? |
| Patient Readmission | 2 | 2019 | 1543 | 0.19 | Why? |
| Bundle-Branch Block | 1 | 2020 | 127 | 0.19 | Why? |
| Aspirin | 2 | 2018 | 1043 | 0.18 | Why? |
| Retreatment | 1 | 2017 | 186 | 0.17 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2020 | 365 | 0.16 | Why? |
| American Heart Association | 1 | 2018 | 347 | 0.16 | Why? |
| Vasodilation | 1 | 2018 | 258 | 0.15 | Why? |
| Microfluidics | 1 | 2017 | 171 | 0.15 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 1510 | 0.14 | Why? |
| Registries | 3 | 2020 | 12327 | 0.14 | Why? |
| Catheterization, Peripheral | 1 | 2018 | 249 | 0.14 | Why? |
| Uric Acid | 1 | 2018 | 285 | 0.14 | Why? |
| Peripheral Arterial Disease | 1 | 2019 | 471 | 0.12 | Why? |
| C-Reactive Protein | 2 | 2021 | 7972 | 0.12 | Why? |
| Electrocardiography | 4 | 2020 | 3957 | 0.12 | Why? |
| Cardiac Catheterization | 1 | 2020 | 882 | 0.12 | Why? |
| Non-ST Elevated Myocardial Infarction | 1 | 2016 | 490 | 0.11 | Why? |
| Coronary Artery Bypass | 1 | 2017 | 629 | 0.10 | Why? |
| Databases, Factual | 3 | 2020 | 6248 | 0.10 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.10 | Why? |
| Postoperative Complications | 2 | 2019 | 5861 | 0.10 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.10 | Why? |
| Ventricular Function, Left | 1 | 2018 | 1555 | 0.10 | Why? |
| Treatment Outcome | 8 | 2019 | 51732 | 0.10 | Why? |
| Cryoelectron Microscopy | 1 | 2017 | 2372 | 0.10 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.09 | Why? |
| United States | 7 | 2020 | 46150 | 0.09 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.09 | Why? |
| Hospital Mortality | 4 | 2020 | 22087 | 0.09 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.08 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.08 | Why? |
| Endothelium, Vascular | 1 | 2018 | 1751 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Female | 13 | 2021 | 380317 | 0.07 | Why? |
| Cardiovascular Diseases | 3 | 2020 | 11497 | 0.07 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.07 | Why? |
| Anti-Inflammatory Agents | 2 | 2021 | 6153 | 0.07 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.07 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.07 | Why? |
| Myocardium | 1 | 2016 | 2323 | 0.07 | Why? |
| Humans | 23 | 2021 | 930598 | 0.07 | Why? |
| Europe | 2 | 2018 | 12702 | 0.07 | Why? |
| New York City | 1 | 2017 | 7432 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.06 | Why? |
| Patient Discharge | 1 | 2019 | 5696 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.06 | Why? |
| Aged | 8 | 2020 | 215776 | 0.06 | Why? |
| Male | 12 | 2021 | 367725 | 0.06 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2018 | 3892 | 0.05 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.05 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 5277 | 0.05 | Why? |
| Intention to Treat Analysis | 1 | 2021 | 673 | 0.05 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.05 | Why? |
| Punctures | 1 | 2018 | 89 | 0.05 | Why? |
| Nitroglycerin | 1 | 2018 | 39 | 0.04 | Why? |
| Aged, 80 and over | 5 | 2019 | 88759 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Dimethylpolysiloxanes | 1 | 2017 | 46 | 0.04 | Why? |
| Gout Suppressants | 1 | 2018 | 54 | 0.04 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Brachial Artery | 1 | 2018 | 107 | 0.04 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
| Regional Blood Flow | 1 | 2018 | 172 | 0.04 | Why? |
| Mentors | 1 | 2020 | 372 | 0.04 | Why? |
| Hospital Costs | 1 | 2019 | 274 | 0.04 | Why? |
| Hospitals, Veterans | 1 | 2018 | 229 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Laboratories, Hospital | 1 | 2020 | 489 | 0.04 | Why? |
| Cause of Death | 2 | 2020 | 4823 | 0.04 | Why? |
| Vasodilator Agents | 1 | 2018 | 344 | 0.04 | Why? |
| Administration, Oral | 1 | 2021 | 2340 | 0.03 | Why? |
| Necrosis | 1 | 2016 | 532 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.03 | Why? |
| Drug Monitoring | 1 | 2021 | 1408 | 0.03 | Why? |
| Diffusion of Innovation | 1 | 2017 | 440 | 0.03 | Why? |
| Cardiovascular System | 1 | 2020 | 750 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Data Collection | 1 | 2020 | 1769 | 0.03 | Why? |
| Double-Blind Method | 1 | 2021 | 5988 | 0.02 | Why? |
| Meta-Analysis as Topic | 1 | 2017 | 1289 | 0.02 | Why? |
| Troponin I | 1 | 2018 | 1298 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.02 | Why? |
| Leadership | 1 | 2020 | 2241 | 0.02 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Cardiology | 1 | 2020 | 2873 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Ambulatory Care | 1 | 2021 | 4947 | 0.02 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.02 | Why? |
| Inpatients | 1 | 2019 | 5161 | 0.02 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
Shah's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(145)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_